LINEAGE CELL THERAPEUTICS IN's ticker is LCTX and the CUSIP is 53566P109. A total of 101 filers reported holding LINEAGE CELL THERAPEUTICS IN in Q2 2022. The put-call ratio across all filers is 0.07 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $97,646 | +361.7% | 82,751 | +451.7% | 0.05% | +381.8% |
| Q2 2023 | $21,150 | -74.2% | 15,000 | -71.7% | 0.01% | -69.4% |
| Q1 2022 | $82,000 | -60.6% | 53,000 | -37.6% | 0.04% | -57.1% |
| Q4 2021 | $208,000 | -5.0% | 85,000 | -2.3% | 0.08% | -13.4% |
| Q3 2021 | $219,000 | +3.3% | 87,000 | +16.8% | 0.10% | +29.3% |
| Q2 2021 | $212,000 | +332.7% | 74,500 | +254.8% | 0.08% | +257.1% |
| Q1 2021 | $49,000 | – | 21,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BROADWOOD CAPITAL INC | 34,935,485 | $41,223,872 | 3.66% |
| Raffles Associates | 1,587,739 | $1,873,532 | 2.48% |
| Defender Capital, LLC. | 5,184,510 | $6,117,722 | 2.22% |
| Prescott General Partners LLC | 1,851,851 | $2,185,184 | 0.14% |
| DCF Advisers, LLC | 82,751 | $97,646 | 0.05% |
| Beirne Wealth Consulting Services, LLC | 45,000 | $63,450 | 0.05% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 781,766 | $922,484 | 0.02% |
| Fort Sheridan Advisors LLC | 83,931 | $99,039 | 0.02% |
| MAI Capital Management | 954,688 | $1,126,532 | 0.02% |
| Piscataqua Savings Bank | 12,499 | $14,623 | 0.01% |